NAD+ patches are marketed as a convenient way to boost levels of nicotinamide adenine dinucleotide, a molecule involved in energy production and cellular repair. But the honest answer is that no published human clinical trial has tested whether a commercially available NAD+ patch raises blood NAD+ levels. The science behind transdermal NAD+ delivery faces a fundamental problem: the NAD+ molecule is large, and skin is designed to keep large molecules out.
The Skin Barrier Problem
Your skin’s outermost layer, the stratum corneum, acts as a gatekeeper. Small, fat-soluble molecules pass through it relatively well, which is why nicotine patches and hormone patches work. NAD+ is neither small nor fat-soluble. It’s a large, water-loving molecule, which makes passive absorption through intact skin extremely unlikely.
Researchers have acknowledged this challenge directly. A 2023 study published in Polymers explored using dissolving microneedles (tiny needle arrays that physically puncture the skin barrier) to deliver NMN, a smaller precursor to NAD+. Even with that technology, the best-performing microneedle formulation released only about 50% of its NMN payload over 18 hours. Standard adhesive patches don’t create these micro-channels in the skin, which raises serious questions about how much active ingredient, if any, actually reaches your bloodstream from a simple stick-on patch.
What the Clinical Evidence Actually Shows
A 2020 review in Pharmaceuticals compiled clinical trials involving NAD-related therapies. Only 11 of the reviewed trials even measured NAD+ levels after the intervention, and results varied so widely that the authors noted they were “almost incomparable” due to a complete lack of standardized measurement methods. None of these trials used consumer NAD+ patches.
The closest relevant evidence comes from topical NAD+ studies, not patches. One small study applied a 1% or 0.3% NAD+ cream daily for four weeks to treat psoriasis and found some therapeutic benefit for skin specifically. Another tested a fat-soluble niacin derivative applied topically for 8 to 18 weeks and measured a roughly 125% increase in NAD+ levels within the skin itself, along with measurable improvements in skin thickness. But increasing NAD+ locally in skin tissue is very different from raising NAD+ throughout the body, which is what patch companies typically promise.
NAD+ Benefits Come From Other Delivery Methods
NAD+ does have real biological effects when it actually reaches tissues. Animal studies have shown that NAD+ administration can improve cognitive function in rats with reduced brain blood flow, protecting against memory deficits in maze-based tests. The molecule plays a genuine role in mitochondrial health, energy metabolism, and DNA repair. These findings aren’t in question.
The issue is delivery. The studies showing benefits used direct injection or IV infusion, where the molecule bypasses the skin entirely. Therapeutic IV doses typically range from 250 to 500 milligrams delivered slowly over two to four hours. Commercial patches often claim to contain similar milligram amounts, but claiming a dose and delivering a dose are not the same thing. Without evidence that the patch formulation can move NAD+ through the skin barrier and into circulation, the milligram number on the label is largely meaningless.
Oral Precursors vs. Patches
Most NAD+ research in humans has used oral precursors like NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide) rather than NAD+ itself. These smaller molecules can survive digestion and get converted into NAD+ inside your cells. Multiple human trials have confirmed that oral NR and NMN supplements do raise blood NAD+ levels, though the degree and duration of that increase varies by dose and individual. If your goal is raising NAD+ levels, oral precursors have a much stronger evidence base than patches.
Skin Irritation and Other Risks
Even setting aside effectiveness, any adhesive patch carries some risk of skin reactions. Irritant contact dermatitis is the most common issue with transdermal systems generally, causing redness, burning, or itching at the application site. Allergic reactions are rarer but possible, and they tend to spread slightly beyond the patch borders. These reactions can come from the adhesive, the backing material, or the active ingredient itself. Because NAD+ patches aren’t regulated as drugs, the quality and composition of adhesives and inactive ingredients can vary significantly between brands.
Why People Report Feeling Better
Anecdotal reports of increased energy or mental clarity after using NAD+ patches do exist. The placebo effect is a likely explanation, particularly for subjective outcomes like “feeling more energetic.” Some patches also contain B vitamins or other compounds alongside NAD+ that could have independent effects if absorbed even partially. Without controlled studies comparing an NAD+ patch to an identical-looking placebo patch, there’s no way to separate a real effect from expectation.
The bottom line is straightforward: there is no published human evidence that NAD+ patches raise whole-body NAD+ levels, and the basic chemistry of skin absorption works against them. The molecule is too large and too water-soluble to passively cross the skin barrier in meaningful amounts. If you’re interested in boosting NAD+, oral precursors like NR and NMN have far more scientific support.